Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process more efficient.
Quibim says its longer-term plan is to create digital twins of the entire human body, serving “dynamic models” that help the ...
JCR Pharmaceuticals Co., Ltd. (TSE 4552; "JCR") announced today that it will present at the 21st Annual WORLDSymposiumtm 2025, held February 3-7, 2025, in San Diego, Calif. The poster presentations ...
Hosted on MSN2d
AI Pharma: 2 Paths to AI-Powered Drug InvestmentThe pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...
Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...
Hosted on MSN2d
The AI advantage in discovering new medicinesWith continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback